BGT vs RGT

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

41LOW

RGT

ARGENTBIO FPO [RGT]

43LOW

Score Breakdown

BGT RGT
Technical
46
35
Catalyst
50
51
Sentiment
50
50
Fundamental
44
34
Momentum
42
44
Risk Gate
24
32

Key Metrics

BGT Metric RGT
$6.6MMarket Cap$5.4M
607KAvg Volume (20d)1.2M
N/AShort InterestN/A
$0.06152-Week High$0.320
$0.01652-Week Low$0.033
+0.0%Daily Change-7.4%
$0.017Reference Price$0.050
-202.2%ROEN/A
N/AProfit MarginN/A

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

RGT Signals

MACD momentum is losing steam
Took a hit — down 16.7% over the last 5 days
Beating the Small Ords index — relative strength of 1.41, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.8 quarters)
Strong revenue growth (+3905%)
Piotroski F-Score weak (2/9, low-confidence approx)
Near 52-week low (5% of range)

Ask Scout AI to compare BGT and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BGT vs RNV →BGT vs SHG →BGT vs SPL →BGT vs TRU →BGT vs TTX →
BGT Full Analysis → RGT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).